When a housing developer want to sell house, first must buy a piece of land, to obtain authorities' approvals, then only launch the project, market it , lastly to construct and complete it. Same goes with the vaccine... not signatures on a piece of paper only...
Nanti vaccine sudah 100%, they will suddenly remember got signed 5years agreement with China.. Remember that even our gloves are not mainly marketed in Msia. Its to oversea.
The total estimated cost required to establish the fill and finish facility is approximately RM20.00 million, of which RM18.22 million is to be funded via the proceeds to be raised from the Proposed Private Placement whilst the remaining RM1.78 million is to be funded via internally generated funds of the Company.
Solutions dump in 20m to setup the facilities. not to main main. So don't worry... collect more while below RM2. I will collect more tomorrow, just withdraw more cash from my FD.
You panic sell ,they absorb cheap .they got nothing to lose but you got nothing to gain....who gains in the end?
No matter what is said, vaccine hope snd optimisism prevails more than anything
Malaysia is not in a position to say no to any vaccine availability to her. Plenty of countries are waiting for it.u can gamble anything except lives..
@mobbs68 other Asean countries hv their own vaccine plan lah.. for example Philippines already ordered some directly from AstraZeneca, they can buy directly fr other producers also why they want to buy fr middleman electrical
The 70 per cent target of Malaysian population to get the Covid-19 vaccine in the first quarter of 2021, will focus on adults to enable the country to reach the herd immunity threshold under the National Immunisation Plan.
To achieve the remaining target, Khairy said the government are in talks with other Covid-19 vaccine manufacturing companies. -Bernama
Have you not heard of exclusive distributorship? What do u know about marketing? Not every single thing you can buy directly from manufacturer They don't entertain u.
Let them talk, to give you guys more confident here is I have met up with somebody and the Vaccine Ad5-Ncov will carry out their trial by this Friday only.. result only will know by near to end of this month. Also there are insider news saying that The factory for fill and finish had started searching for the right place, hopefully they can final the location in PG bayan Lepas. We are at the very early stage to buy in. Today sure over RM2.00. Solution is not only sole distributor for Asean countries, but also conduct for production (fill and finish) which is more profitable. I say today limit up. Solution is the Spade Ace in vaccine. Today I will give beautiful opening at 1.98.
Be grateful to have this solution stock. Be grateful to have Ad5-Ncov production soon in PG. Be grateful to have consecutive days rising in stock price.
Gratitude and Love makes us strong. Cheers for opening at 1.98
1) To be a vaccine distributor, one can conclude via government or via own effort, with the manufacturers (companies that produciing vaccines). 2) Seeking approval via government is much more easier relatively via own effort. 3) KJ's comments is fair and common remarks. Observations is not inclusive of ongoing negotiations between private companies and government (which some feasible at final stage). 4) Once concluded announcement can be expected. 5) As for adverse remarks, just read the observations (with their own"facts"), during initial stage of "glove era/cycle" and compare the comments with the increment/boost in glove share prices.
We refer to the Company’s announcements dated 19 August 2020, 24 August 2020, 27 August 2020, 2 September 2020, 23 September 2020 and 24 September 2020. The Board of Directors of Solution Group Berhad (“Board”) wishes to announce that our subsidiary, Solution Biologics Sdn Bhd (“SOLBIO”), had on 30 October 2020 received a Letter of Authorisation (“LOA”) from CanSino Biologics Inc. (“CanSino”, SHSE: 688185, HKEX:06185).
The estimated 1 billion yearly output would be enough for China to meet domestic demand as well as supply foreign countries, Su said, noting that joining COVAX would also offer "double insurance" for China's vaccine supply.
Chinese companies also hailed the participation and actively prepare to expand production to meet international demand.
"The COVAX facility is especially important to developing countries as it ensures equal access to COVID-19 vaccines for both developed and developing countries," Dongxu Qiu, Senior Vice President and Co-Founder at CanSino Biologics Inc., said in an interview with CGTN on Friday.
Trump just signed an executive order basically reserving all of Pfizer's vaccine for Americans only ..... and Pfizer has supply chain issues which will limit production. This means that certain countries which have signed purchase agreements with Pfizer will not get the vaccines. Thus, most countries will only get Chinese vaccines.
Trump just signed an executive order effectively reserving Pfizer's vaccine for Americans only and Pfizer is facing supply chain issues. D So although we have signed a purchase agreement with Pfizer, we won't be able to get Pfizer's vaccines. Thus the developing countries will be getting only Chinese vaccines.
08/12/2020 8:02
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
limlaopeh
416 posts
Posted by limlaopeh > 2020-12-07 22:13 | Report Abuse
Run tomorrow is too late